Aspen Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$811K Buy
6,310
+11
+0.2% +$1.29K 0.22% 107
2026
Q1
$758K Buy
6,299
+330
+6% +$38.1K 0.23% 100
2025
Q4
$628K Buy
+5,969
New +$560K 0.19% 115
2025
Q1
Sell
-7,997
Closed -$796K 151
2024
Q4
$796K Sell
7,997
-1,085
-12% -$112K 0.37% 72
2024
Q3
$1.03M Buy
9,082
+107
+1% +$12.7K 0.48% 60
2024
Q2
$1.11M Buy
8,975
+935
+12% +$120K 0.55% 52
2024
Q1
$1.06M Buy
8,040
+823
+11% +$101K 0.54% 54
2023
Q4
$787K Buy
7,217
+340
+5% +$35.3K 0.44% 69
2023
Q3
$707K Buy
6,877
+2,185
+47% +$236K 0.43% 67
2023
Q2
$541K Hold
4,692
0.32% 83
2023
Q1
$499K Sell
4,692
-70
-1% -$7.56K 0.32% 84
2022
Q4
$528K Hold
4,762
0.35% 83
2022
Q3
$410K Hold
4,762
0.27% 99
2022
Q2
$434K Buy
4,762
+20
+0.4% +$1.77K 0.27% 99
2022
Q1
$389K Hold
4,742
0.2% 111
2021
Q4
$363K Sell
4,742
-150
-3% -$11.9K 0.18% 119
2021
Q3
$367K Sell
4,892
-182
-4% -$13.8K 0.19% 112
2021
Q2
$395K Sell
5,074
-270
-5% -$20.1K 0.21% 108
2021
Q1
$393K Sell
5,344
-262
-5% -$19.3K 0.22% 103
2020
Q4
$438K Buy
5,606
+89
+2% +$6.81K 0.26% 94
2020
Q3
$437K Sell
5,517
-157
-3% -$12.3K 0.29% 86
2020
Q2
$419K Sell
5,674
-105
-2% -$7.91K 0.3% 85
2020
Q1
$424K Sell
5,779
-262
-4% -$20.6K 0.37% 74
2019
Q4
$524K Sell
6,041
-330
-5% -$27.1K 0.33% 81
2019
Q3
$512K Hold
6,371
0.34% 81
2019
Q2
$510K Sell
6,371
-157
-2% -$12K 0.34% 81
2019
Q1
$518K Hold
6,528
0.36% 79
2018
Q4
$476K Hold
6,528
0.38% 81
2018
Q3
$442K Buy
6,528
+147
+2% +$9.37K 0.29% 94
2018
Q2
$370K Sell
6,381
-129
-2% -$7.28K 0.26% 103
2018
Q1
$338K Sell
6,510
-1,205
-16% -$65.1K 0.24% 107
2017
Q4
$414K Hold
7,715
0.29% 97
2017
Q3
$471K Hold
7,715
0.35% 81
2017
Q2
$472K Hold
7,715
0.36% 78
2017
Q1
$468K Hold
7,715
0.35% 75
2016
Q4
$433K Hold
7,715
0.33% 76
2016
Q3
$459K Sell
7,715
-32
-0.4% -$1.87K 0.36% 70
2016
Q2
$426K Hold
7,747
0.35% 71
2016
Q1
$391K Sell
7,747
-209
-3% -$10.2K 0.36% 67
2015
Q4
$401K Hold
7,956
0.4% 69
2015
Q3
$375K Sell
7,956
-236
-3% -$12.5K 0.37% 75
2015
Q2
$445K Hold
8,192
0.37% 71
2015
Q1
$449K Sell
8,192
-145
-2% -$8.21K 0.36% 71
2014
Q4
$452K Sell
8,337
-214
-3% -$11.9K 0.38% 73
2014
Q3
$484K Sell
8,551
-15,527
-64% -$872K 0.4% 64
2014
Q2
$1.33M Sell
24,078
-1,079
-4% -$58.9K 0.81% 41
2014
Q1
$1.36M Sell
25,157
-230
-0.9% -$11.9K 0.87% 37
2013
Q4
$1.21M Buy
25,387
+116
+0.5% +$5.3K 0.81% 42
2013
Q3
$1.15M Sell
25,271
-32
-0.1% -$1.46K 0.81% 38
2013
Q2
$1.12M Buy
+25,303
New +$1.13M 0.76% 39

Other funds holding MRK

Aspen Investment Management's MRK Position: Q2 2026 in Review

Aspen Investment Management increased its Merck (MRK) stake by 0.17% in Q2 2026, buying an estimated $1.29K and bringing the position to 6,310 shares worth $811K. The position accounts for 0.22% of the portfolio, ranked #107.

Aspen Investment Management first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.36M in Q1 2014. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aspen Investment Management held 6,310 shares of Merck worth $811K as of Q2 2026.
  • Aspen Investment Management bought 11 Merck shares in Q2 2026, an estimated $1.29K.
  • Merck made up 0.22% of Aspen Investment Management's portfolio in Q2 2026, its #107 holding.
  • Aspen Investment Management first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • Aspen Investment Management's Merck position peaked at $1.36M in Q1 2014.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aspen Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.